跳至主要内容
临床试验/NCT04142645
NCT04142645已完成不适用

Pilot Study of the OptiMEDs Intervention: a Complex Intervention for Multidisciplinary Medication Review (Including Nurses, Pharmacists, and Physicians) in Nursing Homes, With ICT-support for the Evaluation of the Appropriateness of Prescribing and for Side-effect Monitoring

University Ghent3 个研究点 分布在 1 个国家目标入组 148 人开始时间: 2019年10月9日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
148
试验地点
3
主要终点
functionality problems

研究概览

简要总结

Pilot study of the OptiMEDs intervention: a complex intervention for multidisciplinary medication review (including nurses, pharmacists, and physicians) in nursing homes (NH), with ICT-support for the evaluation of the appropriateness of prescribing and for side-effect monitoring.

详细描述

The interest in improving the pharmacotherapy of older adults in nursing homes is growing. The OptiMEDs interventions intends to support the decision of GPs regarding the pharmacotherapy of older adults through the combination of an electronic decision support tool (for the appraisal of potentially inappropriate medication use, anticholinergic use, or medications that can be de-prescribed in view of limited life expectancy) with focussed nurse observations (guided by a list of potential medication symptoms based on the individual medication chart of the resident), that will serve as the basis for a multidisciplinary medication review with the input of the GP, community pharmacist and nurse.

The aim of the OptiMEDs intervention is to obtain a more appropriate, safer, and more cost-effective pharmacotherapy in nursing home residents (e.g. less medication-related symptoms, less potentially inappropriate prescribing, a better quality of life, less hospitalisations, health care usage, or mortality)

Before investigating the effectiveness of the OptiMEDs intervention in a large pragmatic clinical trial comparing results of the intervention with standard of care, a pilot study will be undertaken. The aim of the pilot study is to test the feasibility and acceptability of all components of the OptiMEDs interventions in 3 nursing homes in Flanders, Belgium.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Other
盲法
None

入排标准

年龄范围
65 Years 至 —(Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •for nursing homes:
  • •located in East Flanders
  • •size: > 100 beds
  • •mixed population of high care dependent and low care-dependent residents with and without dementia
  • •software of Care Solutions or Farmad is used for electronic handling of the medication chart
  • •the NH management as well as the responsible CRA and the community pharmacist who delivers the medication in the NH give their written agreement to participate
  • •Inclusion criteria for residents:
  • •All residents of all wards of the participating nursing homes will be considered for inclusion if they meet the following inclusion criteria:
  • •aged 65 years or older
  • •mentally fit as well as cognitive impaired NH residents will be included after Informed Consent given by the resident (mentally capable residents) or his representative (cognitive impaired residents, defined as a sumscore of 6 or more on the KATZ items of disorientation in time and place).

排除标准

  • •for residents
  • •Residents will not be considered for inclusion if:
  • •they have a limited life-expectancy (less than 3 months, as judged and documented by the treating GP)
  • •they are residing in a short-stay / revalidation bed
  • •GP refused to have his NH residents included in this pilot

研究组 & 干预措施

Intervention

Experimental

The intervention group (i.e. all eligible and consented residents of 2 NHs) will receive the OptiMEDs intervention: the combination of an electronic decision support tool (for the appraisal of potentially inappropriate medication use, anticholinergic use, or medications that can be de-prescribed in view of limited life expectancy) with focused nurse observations (using a list of potential medication-related symptoms based on the individual medication chart of the nursing home residents), that will serve as the basis during a multidisciplinary medication review with the input of GPs, trained community pharmacists and nurses.

干预措施: OptiMEDs (Device)

Control

No Intervention

The control group (i.e. all eligible and consented residents of one control NH) will receive usual care .

结局指标

主要结局

functionality problems

时间窗: 6 months

Number of functionality problems (n)

practical problems

时间窗: 6 months

listing of practical problems for organizing the medication chart review

workload

时间窗: 6 months

Timing of workload for nurses \& pharmacists regarding the use of OptiMEDs (time)

medication chart review

时间窗: 6 months

duration of a medication chart review by GP and nurse (time)

GPs that refuse

时间窗: 6 months

number of GPs that refuse to participate / accept to participate (n)

Optimeds completion

时间窗: 6 months

Number of symptom observations and medication reviews completed (on time) (n)

Software/user problems

时间窗: 6 months

monthly number of interventions for software/user problems (n)

non-consenting eligible residents (n)

时间窗: 6 months

Number of non-consenting eligible residents legally capable to give consent (n)

Non-consenting proxies for eligible residents (n)

时间窗: 6 months

Number of non-consenting proxies for eligible residents legally not capable to give consent

次要结局

  • Number of Consultations(4 months)
  • number of anticholinergics(4 months)
  • patient-related alertness(4 months)
  • patient-related falls(4 months)
  • number of medications(4 months)
  • patient-related QOL(4 months)
  • Number of Hospitalization(4 months)
  • number of candidates for de-prescribing(4 months)
  • patient-related pain(4 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验

OptiMEDs Pilot Study | 临床试验